Status:
COMPLETED
Neurosurgery Patient Outcomes in Treating Spinal Disorders
Lead Sponsor:
Greenwich Hospital
Collaborating Sponsors:
American Association of Neurological Surgeons
Conditions:
Symptomatic Lumbar Disc Herniation
Symptomatic Grade I Lumbar Spondylolisthesis
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The creation of a multi-center cooperative research group encompassing academic and community-based spinal practices . . .
Eligibility Criteria
Inclusion
- Grade I degenerative or isthmic spondylolisthesis recalcitrant to non-invasive therapies for at least 3 months or Lumbar degenerative disc herniation with radiculopathy refractory to non-invasive therapies for at least 6 weeks
Exclusion
- History of previous lumbar spine surgery
- Significant motor weakness (3/5) (i.e. foot drop)
- Cancer, infection, or fracture
- Pregnancy
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT01220921
Start Date
September 1 2010
End Date
September 1 2012
Last Update
December 4 2015
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California - San Francisco
San Francisco, California, United States, 94143
2
Greenwich Hospital
Greenwich, Connecticut, United States, 06830
3
Yale New Haven Hospital
New Haven, Connecticut, United States, 06520
4
Johns Hopkins Hospital
Baltimore, Maryland, United States